Skip to main content
. 2017 Nov 30;18(12):2576. doi: 10.3390/ijms18122576

Table 1.

Glioblastoma aptamers and their SELEX methods.

Aptamer Target SELEX Method Positive Selection Negative Selection Reference(s)
A3, A4 Unknown Differential cell-SELEX CD133+ TIC CD133− cells; human neural progenitor cells [72]
TTA1 Tenascin-C Crossover-SELEX U251 cells; human Tenascin-C No negative selection [66,73]
GBI-10 Tenascin-C Cell-SELEX U251 cells No negative selection [74,75]
Gint4.T PDGFRβ Cell-SELEX U87MG cells No negative selection [76,77]
GL21.T Axl Differential cell-SELEX U87MG cells T98G cells [77,78,79,80]
U2 EGFRvIII Differential cell-SELEX U87MG-EGFRvIII cells U87MG cells [81]
Aptamer 32 EGFRvIII Differential cell-SELEX U87MG-EGFRvIII cells U87MG cells [82,83,84]
E07 EGFR; EGFRvIII Protein-SELEX Human EGFR No negative selection [85,86,87]
GMT 3–9 Unknown Differential cell-SELEX A172 cells No negative selection [88]
GBM128, GBM131 Unknown Differential cell-SELEX U118-MG cells SVGp12 cells [89]